Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;101(9):e378-81.
doi: 10.3324/haematol.2016.141929.

Complementarity determining region-independent recognition of a superantigen by B-cell antigen receptors of mantle cell lymphoma

Affiliations

Complementarity determining region-independent recognition of a superantigen by B-cell antigen receptors of mantle cell lymphoma

Michael Fichtner et al. Haematologica. 2016 Sep.
No abstract available

Keywords: B-cell receptor; SpA; mantle cell lymphoma; protein A; superantigen.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
IGHV3 expressing MCL BCRs bind to the staphylococcal protein A leading to BCR pathway activation. (A) Amino acid sequence alignment of the Staphylococcus aureus protein A (SpA) binding motif of all IGHV3-containing MCL-BCR- as well as some CLL-BCR- and FL-BCR-derived immunoglobulins. The motif is indicated in the top row. Deviations are highlighted with black background. (B) ELISA with different Fab immunoglobulin fragments derived from MCL, CLL and FL samples to determine their reactivity to SpA. Note that FL10 harbored a highly mutated SpA-motif and is completely inert. (C) Ca2+ flux analysis of Ramos cells expressing MCL-derived membrane-bound immunoglobulins (mIgs). Transduced cells were BCR-stimulated by adding either SpA (bottom row) or an anti-human-Fab antibody (top row). The time of addition is indicated by the gaps in the plots. Non-transduced cells served as control.

Similar articles

Cited by

References

    1. Young RM, Staudt LM. Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov. 2013;12(3):229–243. - PMC - PubMed
    1. Wang ML, Rule S, Martin P, et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med. 2013;369(6):507–516. - PMC - PubMed
    1. Hervé M, Xu K, Ng Y-S, et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest. 2005;115(6):1636–1643. - PMC - PubMed
    1. Iacovelli S, Hug E, Bennardo S, et al. Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL. Blood. 2015;125(10):1578–1588. - PMC - PubMed
    1. Minden MD, Übelhart R, Schneider D, et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012;489(7415):309–312. - PubMed

Publication types

MeSH terms

LinkOut - more resources